| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004565419 |
| P356 | DOI | 10.1186/BCR2091 |
| P932 | PMC publication ID | 2481487 |
| P698 | PubMed publication ID | 18460216 |
| P5875 | ResearchGate publication ID | 5393196 |
| P2093 | author name string | Yun Yen | |
| Li Zhong | |||
| Kemp H Kernstine | |||
| Xu Gao | |||
| Kun Ge | |||
| Xiao-gang Zhang | |||
| Jian-fei Wang | |||
| Jin-chi Zu | |||
| Long-hua Zhao | |||
| Wanping Hu | |||
| Wei-ke Shen | |||
| P2860 | cites work | Disease proteomics | Q35084579 |
| Generation of cDNA expression libraries enriched for in-frame sequences | Q36032717 | ||
| Human tumor antigens recognized by T lymphocytes: implications for cancer therapy. | Q41130657 | ||
| Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. | Q42803871 | ||
| Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma | Q44464362 | ||
| NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors | Q47937083 | ||
| Anti-p53 in Breast Cancer: Concordance of Different Assay Procedures and Association with p53 Antigen Expression | Q61970382 | ||
| Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events | Q73032215 | ||
| Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer | Q73341901 | ||
| High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer | Q73863091 | ||
| Autoantibodies to the 90kDa heat shock protein and poor survival in breast cancer patients | Q77495235 | ||
| Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients | Q77725499 | ||
| Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer | Q77795871 | ||
| Harnessing immunity for cancer marker discovery | Q78745718 | ||
| Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy | Q79318066 | ||
| Autoantibodies in breast cancer: their use as an aid to early diagnosis | Q79905914 | ||
| Antigens recognized by autologous antibody in patients with renal-cell carcinoma | Q22010600 | ||
| Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library | Q24291069 | ||
| Gapped BLAST and PSI-BLAST: a new generation of protein database search programs | Q24545170 | ||
| Human neoplasms elicit multiple specific immune responses in the autologous host | Q24564371 | ||
| A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening | Q24564781 | ||
| Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression | Q28204114 | ||
| Characterization of human colon cancer antigens recognized by autologous antibodies | Q28272525 | ||
| Cancer statistics, 2007 | Q29547293 | ||
| Role of amplified genes in the production of autoantibodies | Q30656894 | ||
| Using protein microarray as a diagnostic assay for non-small cell lung cancer | Q30796772 | ||
| Profiling tumor-associated antibodies for early detection of non-small cell lung cancer | Q30830942 | ||
| Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library | Q33184085 | ||
| Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancer | Q33200424 | ||
| Tumor associated antigen recognition by autologous serum in patients with breast cancer. | Q33209639 | ||
| Autoantibody signatures in prostate cancer | Q33223730 | ||
| Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis | Q33227518 | ||
| Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. | Q33232102 | ||
| American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer | Q33303529 | ||
| New approaches in cancer treatment | Q33838656 | ||
| An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer | Q33933918 | ||
| Advances in the treatment of non-small cell lung cancer: molecular markers take the stage | Q34206107 | ||
| Novel approaches in the treatment of non-small-cell lung cancer. | Q34218815 | ||
| Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies | Q34219323 | ||
| Identification of tumour-associated T-cell epitopes for vaccine development | Q34718188 | ||
| A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells | Q35053221 | ||
| P433 | issue | 3 | |
| P921 | main subject | breast cancer | Q128581 |
| autoantibody | Q785022 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | R40 | |
| P577 | publication date | 2008-05-07 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Autoantibodies as potential biomarkers for breast cancer | |
| P478 | volume | 10 |
| Q34330451 | A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer. |
| Q30494036 | ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function |
| Q37253388 | Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay |
| Q61445141 | An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter |
| Q36682206 | Antibody profiling with protein antigen microarrays in early stage cancer |
| Q47965507 | Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia. |
| Q39858992 | Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients |
| Q37635618 | Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag. |
| Q50553645 | Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer |
| Q36896106 | Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer |
| Q34665049 | Autoantibodies to Tailor-Made Panels of Tumor-Associated Antigens in Breast Carcinoma |
| Q33633387 | Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma |
| Q64120727 | Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA) |
| Q84630015 | Autoantibody against hypoxia-inducible factor prolyl hydroxylase-3 is a potential serological marker for renal cell carcinoma |
| Q35377236 | Autoantibody signatures: progress and perspectives for early cancer detection |
| Q36204798 | Biologic characteristics of premalignant breast disease |
| Q37120321 | Cancer prognostics by direct detection of p53-antibodies on gold surfaces by impedance measurements. |
| Q27011319 | Collagen VI and hyaluronan: the common role in breast cancer |
| Q38430487 | Comparative Transcriptomic Analysis of Porcine Peripheral Blood Reveals Differentially Expressed Genes from the Cytokine-cytokine Receptor Interaction Pathway Related to Health Status |
| Q33797159 | Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer |
| Q37215382 | Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera |
| Q64097298 | Gonadotropin regulation of ankyrin-repeat and SOCS-box protein 9 (ASB9) in ovarian follicles and identification of binding partners |
| Q35143308 | How the ankyrin and SOCS box protein, ASB9, binds to creatine kinase |
| Q34467807 | Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer |
| Q37579900 | Identifying autoantibody signatures in cancer: a promising challenge. |
| Q33949907 | Immunogenicity of autoantigens |
| Q37478666 | Improving seroreactivity-based detection of glioma |
| Q53656096 | Is there a general autoantibody signature for cancer? |
| Q36214596 | Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma |
| Q38331911 | Multicenter study identified molecular blood-born protein signatures for Wilms Tumor |
| Q27679000 | Multimeric Complexes among Ankyrin-Repeat and SOCS-box Protein 9 (ASB9), ElonginBC, and Cullin 5: Insights into the Structure and Assembly of ECS-type Cullin-RING E3 Ubiquitin Ligases |
| Q58563203 | Multiplexed Autoantibody Signature for Serological Detection of Canine Mammary Tumours |
| Q33761501 | Optimization of phage-immobilized ELISA for autoantibody profiling in human sera |
| Q36172882 | Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection |
| Q34309299 | Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis |
| Q34475795 | Prognostic and Diagnostic Value of Spontaneous Tumor‐Related Antibodies |
| Q46186295 | RELT family members activate p38 and induce apoptosis by a mechanism distinct from TNFR1. |
| Q34566729 | SEREX: a promising approach for identification of thyroid cancer serological biomarkers |
| Q51066755 | Serum GFAP autoantibody as an ELISA-detectable glioma marker |
| Q37622471 | Serum autoantibodies as biomarkers for early cancer detection |
| Q52367069 | The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling |
| Q35187373 | The network of antigen-antibody reactions in adult women with breast cancer or benign breast pathology or without breast pathology |
| Q38780263 | Tumour-Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta-Analysis |
| Q34037876 | Use of autoantibodies to detect the onset of breast cancer |
Search more.